三阴性乳腺癌放射治疗的研究进展

doi:10.11904/j.issn.1002-3070.2016.02.019

摘要/Abstract

摘要： 三阴性乳腺癌是乳腺癌的一个重要临床亚型,易复发、转移,预后较差。放射治疗是乳腺癌的有效局部治疗手段,可以降低局部复发风险。本文将从三阴性乳腺癌的生物学特征,保乳术后、改良根治术后放疗,放疗时机,放射增敏等方面的进展进行阐述,以期对三阴性乳腺癌预后的改善有所帮助。

关键词: 三阴性乳腺癌, 保乳术, 放射治疗, 放射增敏

Abstract: The triple negative breast cancer is one of importance in clinical subtypes of breast cancer,which is easy to recur and metastasis,and its prognosis is very poor.Radiotherapy,as an effective method for breast cancer,can reduce the risk of local recurrence.This article elaborates its characteristics,the progress of radiotherapy in the breast conserving surgery and modified radical mastectomy in triple negative breast cancer,when is the appropriate time for radiotherapy and radiotherapy sensitization,and hope that it will be helpful to the treatments.

Key words: Triple negative breast cancer, Breast conserving surgery, Radiotherapy, Radiotherapy sensitization

中图分类号:

R737.9

罗红雨, 李嘉琪, 栾瑾微, 张思亮综述, 李香兰审校. 三阴性乳腺癌放射治疗的研究进展[J]. 实用肿瘤学杂志, 2016, 30(2): 180-183.

LUO Hongyu, LI Jiaqi, LUAN Jinwei, ZHANG Siliang, LI Xianglan. The progress of radiotherapy in triple negative breast cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(2): 180-183.

参考文献

1 Meena M.Radiation therapy in the locoregional treatment of triple-negative breast cancer[J].Lancet Oncol,2015,16(3):113-122.
2 Boyle P.Triple-negative breast cancer:epidemiological considerations and recommendations[J].Ann Oncol,2012,23(6):7-12.
3 Sioshansi S,Ehdaivand S,Cramer C,et al.Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy[J].Cancer,2012,118(16):3893-3898.
4 Part A,Adamo B,Cheang MC,et al.Molecular characterization of basal-like and non-basal-like triple-negative berast cancer[J].Oncologist,2013,18(2):123-133.
5 Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767.
6 Lehmann BD,Pietenpol JA.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes[J].J Pathol,2014,232(2):142-150.
7 Lehmann BD,Bauer JA,Chen X,et al.Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies[J].J Clin Invest,2011,121(7):2750-2767.
8 Gazinska P,Grigoriadis A,Brown JP,et al.Comparison of basal-like triple-negative breast cancer defined by morphology,immunohistochemistry and transcriptional profiles[J].Mod Pathol,2013,26(7):955-966.
9 杜娟,阮祥燕.三阴乳腺癌的特点及研究进展[J].首都医科大学学报,2015,36(4):578-582.
10 Perou CM.Molecular stratification of triple-negative breast cancers[J].Oncologist,2010,15(5):39-48.
11 Kyndi M,Srensen FB,Knudsen H,et al.Estrogen receptor,progesterone receptor,HER-2,and response to postmastectomy radiotherapy in high-risk breast cancer:the Danish Breast Cancer Cooperative Group[J].Clin Oncol,2008,26(9):1419-1426.
12 Freedman GM,Anderson PR,Li T,et al.Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation[J].Cancer,2009,115(5):945-946.
13 Pignol JP,Rakovitch E,Olivotto IA.et al.Is breast conservation therapy superior mastectomy for women with triple-negative breast cancers?[J].Clin Oncol,2011,29(21):2841-2843.
14 Lauche O,Azria D,Riou O,et al.Radiosensitivity in breast cancer[J].Cancer Radiother,2015,19(4):237-240.
15 Haviland JS,Owen JR,Dewar JA,et al.The UK standardisation of breast radiotherapy(START)trials of radiotherapy hypofraction-ation for treatment of early breast cancer:10-year follow-up results of two randomised controlled trials[J].Lancet Oncol,2013,14(11):1086-1094.
16 王伟,王捷.乳腺癌不同放疗分割模式的研究进展[J].肿瘤预防与治疗,2015,28(3):174-178.
17 冶秀鹏,马小萍,包慎,等.早期乳腺癌保乳术后大分割放疗的Meta 分析[J].现代肿瘤医学,2015,23(16):2292-2230.
18 余子豪.乳腺癌放射治疗进展[J].中国实用外科杂志,2015,35(97):784-786.
19 Vesonesi U,Oreccchia R,Maisonneuve P,et al.Intraoperative radiotherapy versus external radiotherapy for early breast cancer(ELIOT):a randomised controlled equivalence trail[J].Lancet Oncol,2013,14(13):1269-1277.
20 Fastner G,Hauser-Kronberger C,Moder A.Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery[J].Stralenther Onkol,2016,192(1):1-7.
21 Vaidya JS,Wenz F,Bulsara M,et al.Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer:5-year results for local control and overall survival from the TARGIT-A randomised trail[J].Lancet,2014,383(9917):603-613.
22 Stull TS,Goodwin CM,Gracely EJ,et al.A single-institution review of accelerated partial breast irradiation in patients considered ‘cautionary’ by the American Society for Radiation Oncology[J].Ann Surg Oncol,2012,19(2):553-559.
23 Wilkinson JB,Reid RE,Shaitelman SF,et al.Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast iradiation[J].Radiat Oncol Biol Phys,2011,81(3):159-164.
24 Abi-Raad R,Boutrus R,Wang R,et al.Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy:implications for postmastectomy radiotherapy[J].Int J Radiat Oncol Biol Phys,2011,81(3):e151-e157.
25 Wang J,Shi M,Ling R,et al.Increased risk of locoregional recurrence for women with T_1-2N₀ triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy[J].Clin Oncol,2011,29(21):2852-2858.
26 Abdukarim BS,Cuartero J,Hanson J,et al.Increased risk of locoregional recurrence for women with T_1-2N₀ triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy[J].Clin Oncol,2011,29(21):2852-2858.
27 Rowell NP.Radiotherapy to the chest wall following mastectomy for node-negative breast cancer:a systematic review[J].Radiother Oncol,2009,91(1):23-32.
28 Hickey BE,Fmncis DP,Lehman M.Sequencing of chemotherapy and radiotherapy for early breast cancer[J].Cochrane Database Syst Rev,2013(4):323-331.
29 Buchholz TA,Austin-Seymour MM,Moe RE,et a1.Effect of delay in radiation in the combined modality treatment of breast cancer[J].Int Radiat Oncol Biol Phys,1993,26(1):23-35.
30 李冰馨,傅深.三阴性乳腺癌放射治疗相关机制的研究进展[J].中国癌症杂志,2014,24(11),865-870.
31 Hirai T,Shirai H,Fujimori H,et al.Radiosensitization effect of poly(ADP-ribose)polymerase inhibition in cells exposed to low and high liner energy transfer radiation[J].Cancer Science,2012,103(6):1045-1050.
32 范雅文,张旭辉,张嵘,等.三阴乳腺癌的异质性及靶向治疗[J].生物技术通讯,2015,26(3):442-445.
33 Heravi M,Kumala S,Rachid Z,et al.ZRBA1,a mixed EGFR/DNA targeting molecule,potentiates radiation response through delayed DNA damage repair process in a triple negative breast cancer model[J].Radiat Oncol Biol Phys,2015,92(2):399-406.
34 Martinel-Lamas DJ,Cortina JE,Ventura C,et al.Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer[J].Cancer Biol Ther,2015,16(1):137-148.
35 杨芳,管晓翔.MircroRNA在三阴性乳腺癌发生发展中的作用[J].临床肿瘤学杂志,2014,19(10):950-952.
36 Ren YQ,Fu F,Han J.MiR-27a modulates radiosensitivity of triple-negative breast cancer(TNBC)cells by targeting CDC27[J].Med Sci Monit,2015,6(21):1297-1303.

[1]	李嘉琪,栾瑾微,张,玉,李香兰. 763例三阴性乳腺癌临床病理特征及复发、转移影响因素分析[J]. 实用肿瘤学杂志, 2019, 33(3): 244-249.
[2]	李珊,赵春波,乔文波. 术中放疗在胰腺癌中的应用进展[J]. 实用肿瘤学杂志, 2019, 33(3): 280-283.
[3]	张攀, 张迪综述, 戴晓波审校. 复发鼻咽癌再程放射治疗的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 92-96.
[4]	杜夜生, 胡松柳, 徐向英. 非小细胞肺癌寡转移的立体定向放射治疗研究[J]. 实用肿瘤学杂志, 2018, 32(2): 154-158.
[5]	孙明亮, 徐建宇, 徐向英. 早期非小细胞肺癌立体定向放疗的相关研究[J]. 实用肿瘤学杂志, 2018, 32(1): 53-56.
[6]	刘国慧, 谷安鑫, 殷洪涛, 曹阳, 贺云龙, 王春波, 鄂明艳. 原苏木素A对胃癌SGC-7901细胞系放疗增敏作用的研究[J]. 实用肿瘤学杂志, 2017, 31(6): 500-505.
[7]	赵永瑞, 徐建堃审校. PET/MRI在高级别脑胶质瘤放射治疗中的应用[J]. 实用肿瘤学杂志, 2017, 31(6): 564-568.
[8]	罗佳宁, 郝春成, 张建鑫, 卢江岳, 葛晓峰. 术后辅助放疗对三阴性乳腺癌患者预后的影响[J]. 实用肿瘤学杂志, 2017, 31(5): 411-416.
[9]	王赫隆, 云惟康, 王业伟, 冯丽娜, 白彦灵. 三种照射技术在髓母细胞瘤放射治疗中的剂量学分析[J]. 实用肿瘤学杂志, 2017, 31(5): 436-440.
[10]	汤大北, 金艳, 龚振琴, 初众, 曹仲茹, 张清媛. 三阴性乳腺癌中miRNA-124表达与E-钙黏蛋白及雄激素受体的关系[J]. 实用肿瘤学杂志, 2017, 31(2): 97-101.
[11]	陈子印, 钱茂森, 潘慧莹. 非共面野在早期非小细胞肺癌立体定向放射治疗方面的剂量学优势[J]. 实用肿瘤学杂志, 2017, 31(2): 142-146.
[12]	余长艳, 甄丽娜, 李洪滨, 张悦, 张清媛. 肿瘤相关巨噬细胞在三阴性乳腺癌中的表达与临床病理因素及预后关系的研究[J]. 实用肿瘤学杂志, 2017, 31(1): 1-6.
[13]	曲媛媛，徐向英，庄明，殷洪涛，胡松柳，王春波，曹阳. 尼妥珠单抗对肺癌A549细胞系的体外放射增敏效应[J]. 实用肿瘤学杂志, 2016, 30(6): 497-501.
[14]	吴煜良，何松美，张纯，吴伟艺，崔顺景，赵艳海. 迭代次数在宫颈癌术后调强放疗计划中对子野权重优化的影响[J]. 实用肿瘤学杂志, 2016, 30(6): 507-510.
[15]	刘伟综述, 李惠艳审校. 表皮生长因子受体与放射敏感性关系的研究进展[J]. 实用肿瘤学杂志, 2016, 30(3): 275-278.